These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function. Benvenisty AI; Cohen D; Stegall MD; Hardy MA Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654 [TBL] [Abstract][Full Text] [Related]
17. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687 [No Abstract] [Full Text] [Related]
18. [A comparative trial of OKT3 and antilymphocyte serum in the preventive treatment of rejection after kidney transplantation in children]. Niaudet P; Murcia I; Jean G; Broyer M Ann Pediatr (Paris); 1990 Feb; 37(2):83-5. PubMed ID: 2138866 [TBL] [Abstract][Full Text] [Related]